Common side effects (rare): Temporary fatigue in first 3-5 days Mild headaches Injection site redness Increased appetite Vivid dreams (uncommon) Serious side effects (very rare): Allergic reaction to peptide Injection site infection (poor technique) Dizziness or lightheadedness Who shouldn't use BPC-157: Pregnant or breastfeeding women Active cancer diagnosis (promotes angiogenesis) Recent retinal surgery (blood vessel growth in eye) Known allergy to peptides Drug interactions: BPC-157 doesn't interact with most medications, but combining with: NSAIDs: BPC-157 protects against NSAID damage (actually beneficial) Blood thinners: Monitor closely due to angiogenesis effects Immunosuppressants: May reduce BPC-157 effectiveness Dosing mistakes to avoid Get the protocol right from the start
In the cohorts studied, the large majority of raised results were explained by supplementation, by liver disease, or by nothing identifiable at all
These therapies can promote a variety of health benefits, such as enhancing muscle growth, supporting weight management, improving skin health, reducing inflammation, and optimizing hormone balance
Antecedent disease and amyotrophic lateral sclerosis: what is protecting whom
Vitamin B12 (hydroxocobalamin, cyanocobalamin): advise patients with known cobalt allergy to be vigilant for sensitivity reactions
Practical and Research Context For researchers and readers using this page as reference material, the compounds sit at similar but not identical points: both are injectable, once-weekly, investigational metabolic peptides with genuine human RCT data a status that already sets them apart from the many research peptides supported only by animal or in-vitro work but neither is an approved medicine, and the two have never been compared directly